LNPEP and breast cancer: OT levels in the pituitary and blood also increased in a rat breast cancer model induced by N-methyl-nitrosourea (NMU)-treatment due to inhibition of insulin-regulated aminopeptidase (an oxytocinase) and decrease of catabolism of OT in the hypothalamus [57].